Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Hypoxia–Immune-Related Gene SLC19A1 Serves as a Potential Biomarker for Prognosis in Multiple Myeloma

25 Jul 2022

Abstract excerpt

Background Multiple myeloma (MM) remains an incurable malignant tumor of plasma cells. Increasing evidence has reported that hypoxia and immune status contribute to the progression of MM. In this research, the prognostic value of the hypoxia–immune-related gene SLC19A1 in MM was evaluated by bioinformatics analysis. Method RNA-sequencing (RNA-seq) data along with clinical information on MM were downloaded from...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer, Hypoxia, and Metabolism
Share to Ferroptosis and cancer prognosis
Share to Multiple Myeloma Research and Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35958555
DOI: 10.3389/fimmu.2022.843369

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Hypoxia–Immune-Related Gene SLC19A1 Serves as a Potential Biomarker for Prognosis in Multiple MyelomaPMID 35958555Read ↗

Impact of hypoxia on the pathogenesis and therapy resistance in multiple myelomaSemantic proximity Read ↗

Characterization and application of a lactate and branched chain amino acid metabolism related gene signature in a prognosis risk model for multiple myelomaSemantic proximity Read ↗

Exploring the Molecular Mechanisms and Shared Genetic Characteristics of Monoclonal Gammopathy of Undetermined Significance and Multiple MyelomaSemantic proximity Read ↗

Focusing on long non-coding RNA dysregulation in newly diagnosed multiple myelomaSemantic proximity Read ↗

<i><scp>ARNT</scp></i>/<scp>HIF</scp>‐1β links high‐risk 1q21 gain and microenvironmental hypoxia to drug resistance and poor prognosis in multiple myelomaSemantic proximity Read ↗

Prognostic value of fatty acid metabolism-related signature and integrated analysis of the immune microenvironment in multiple myelomaSemantic proximity Read ↗

New insights into genetic characteristics between multiple myeloma and COVID‐19: An integrative bioinformatics analysis of gene expression omnibus microarray and the cancer genome atlas dataSemantic proximity Read ↗

Identification and Validation of a Novel RNA-Binding Protein-Related Gene-Based Prognostic Model for Multiple MyelomaSemantic proximity Read ↗

A novel ferroptosis-related gene signature for predicting prognosis in multiple myelomaSemantic proximity Read ↗

Integrative Analysis of Bulk RNA-Seq and Single-Cell RNA-Seq Unveils Novel Prognostic Biomarkers in Multiple MyelomaSemantic proximity Read ↗

Multi-omics analysis of multiple myeloma patients with differential response to first-line treatment.Semantic proximity Read ↗

Characterization of complete lncRNAs transcriptome reveals the functional and clinical impact of lncRNAs in multiple myelomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.